Because a subset of Group 4 medulloblastomas shows high expression of PRDM6 in conjunction with amplification of the MYCN oncogene1,4, we decided to investigate potential synergies between PRDM6 and MYCN expression on tumor development from NES cells. This evidence concerns the gene MYCN and medulloblastoma.